XSHE
300334
Market cap378mUSD
Oct 09, Last price
8.22CNY
1D
-2.03%
1Q
-10.94%
Jan 2017
-54.79%
IPO
-38.43%
Name
Tianjin MOTIMO Membrane Technology Co Ltd
Chart & performance
P/E
—
P/S
10.25
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.91%
Rev. gr., 5y
-12.53%
Revenues
242m
-1.48%
Net income
-33m
L
CFO
19m
P
Dividend
Jun 05, 20170.02 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tianjin MOTIMO Membrane Technology Co.,Ltd specializes in the research, development, manufacturing, and marketing of advanced filtration solutions, including ultra- and micro-filtration membranes, their respective modules, and associated equipment. Beyond its product offerings, the company delivers crucial services such as membrane module replacement, comprehensive membrane engineering, and technical assistance for sewage treatment processes. Furthermore, it ensures client satisfaction through robust technical support and dedicated after-sales services. Founded in 2003, the firm maintains its headquarters in Tianjin, People's Republic of China.
Key people
Huipeng Song
Chief Investment Officer, Deputy General Manager, Secretary of the Board · since 2022
Haibo Liu
Chief Marketing Officer · since 2024
Xiaolong Lu
Chief Scientific Officer · since 2022
Honggang Li
Deputy General Manager · since 2024
Jianhua Yu
Chief Financial Officer, Deputy General Manager · since 2019
Shuhua Zhan
Deputy General Manager, Chief Safety Officer · since 2025
Peng Jiang
Chief Production Officer · since 2021
Ning Fan
General Manager, Director · since 2025
Dong Guo
Director · since 2025
Yi Huang
Director · since 2025
Chunzhi Li
Director · since 2025
Jun Zhai
Director · since 2020
Chunjian Zheng
Director · since 2022
Rong Cui
Independent Director · since 2022
Zhigang Liu
Independent Director · since 2022
Jing Xie
Independent Director · since 2024
Wenzhao Xiong
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||